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A portable centrifugal analyser for liver function screening 
Charles E. Nwankire a,b, Monika Czugalac, Robert Burger a,b, Kevin J. Fraserc, Tríona M. O’Connell a, Thomas 
Glennon a, Blessing E. Onwuliri d,e, Isikaku E. Nduaguibe e, Dermot Diamond e and Jens Ducrée a,b  
Mortality rates of up to 50% have been reported after liver failure due to drug-induced hepatotoxicity and 
certain viral infections(Gao et al. 2008). These adverse conditions frequently affect HIV and tuberculosis 
patients on regular medication in resource-poor settings. Here, we report full integration of sample 
preparation with read-out of a 5-parameter liver assay panel (LAP) on a portable, easy-to-use, fast and cost-
efficient centrifugal microfluidic analysis system (CMAS). Our unique, dissolvable-film based centrifugo-
pneumatic valving was employed to provide sample-to-answer fashion automation for plasma extraction 
(from finger-prick of blood), metering and aliquoting into separate reaction chambers for parallelized 
colorimetric quantification during rotation. The entire LAP completes in less than 20 minutes while using 
only a tenth the reagent volumes when compared with standard hospital laboratory tests. Accuracy of in-situ 
liver function screening was validated by 96 separate tests with an average coefficient of variance (CV) of 
7.9% compared to benchtop and hospital lab tests. Unpaired two sample statistical t-tests were used to 
compare the means of CMAS and benchtop reader, on one hand; and CMAS and hospital tests on the other. 
The results demonstrate no statistical difference between the respective means with 94% and 92% certainty of 
equivalence, respectively.  The portable platform thus saves significant time, labour and costs compared to 
established technologies, and therefore comply with typical restrictions on lab infrastructure, maintenance, 
operator skill and costs prevalent in many field clinics of the developing world. It has been successfully 
deployed in a centralised lab in Nigeria. 
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Introduction 
Liver is the largest solid organ in the body and is largely responsible for metabolism and detoxification.(Gao et al. 2008) Liver function tests 
are widely used in clinical chemistry to assess therapeutic effects and potential medication-induced liver damage, especially when taking 
medications for HIV, tuberculosis and cancer.(Landis et al. 2013; Rahmioglu et al. 2009; Vella et al. 2012) Literature reports suggest that a 
mortality rate of 2 – 28% can be linked with medication-induced liver damage.(Vella et al. 2012) As a result, monitoring of liver function 
when on certain medications has become common practice in developed countries but can be expensive in poor resource areas. This has 
prompted local governments and international funding agencies to set up centralised laboratories for liver function monitoring tests 
especially for HIV patients. Nonetheless, transport logistics and accessibility remains a significant challenge for the majority of these 
patients. Thus it is very important to develop portable point-of-care (PoC) devices that could be used for liver function screening in the field. 
Currently, there are only a handful of sample-to-answer PoC devices available for deployment in the field. Recently, Vella et al.(Vella et al. 
2012) demonstrated an innovative micropatterned paper device for measuring liver function markers from a finger prick of blood.  
Over the last two decades, various microfluidic “lab-on-a-disc” (LoaD) platforms have proven to facilitate full integration and automation of 
laboratory unit operations such as blood separation, metering, aliquoting, mixing, reagent storage and sequential reagent delivery(Ducrée et 
al. 2007; Duford et al. 2013; Honda et al. 2005; Kim et al. 2013; Robert et al. 2013; Steigert et al. 2007; van Oordt et al. 2013) for 
applications in bioprocess,(Nwankire et al. 2013) biomedical,(Godino et al. 2013; Park et al. 2012) food allergen(Tortajada-Genaro et al. 
2011), pathogen detection(Golden et al. 2013) and environmental monitoring.(Czugala et al. 2012; Hwang et al. 2013) Nevertheless, few 
examples of portable sample-to-answer systems with optical read-out have been demonstrated.(Abaxis 2012; Lee et al. 2009) A standard 
computer DVD drive has been proposed for a range of applications including cell counting, food allergen tests and blood analysis.(Imaad et 
al. 2011; Ramachandraiah et al. 2013; Riegger et al. 2007; Tortajada-Genaro et al. 2011; Yu et al. 2012) The Abaxis Piccolo express is a 
LoaD type chemistry analyser, commercially available for the use in veterinary and medical diagnostics.(Abaxis 2012) Lee et al.(Lee et al. 
2009) also demonstrated a portable LoaD system for detection of the Hepatitis B virus. Considering the physical size of these systems, they 
may not be suitable for in-situ screening in resource-poor settings. 
In this paper, we present for the first time full automation of a 5-parameter liver assay panel (LAP) including plasma separation
 and serial aliquoting (Al-Faqheri et al. 2013; Mark et al. 2011) from a single, finger-prick blood sample by our unique dissolvable-film 
based centrifugo-pneumatic valving technology(DUCRÉE et al. 2012; Gorkin III et al. 2012)  on portable, battery-powered centrifugal 
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2. Materials and Methods 
2.1 Integrated microfluidic design and fabrication 
The integrated microfluidic disc features two independent fluidic halves; the calibration and assay panel (Fig 1B) designed using SolidWorks 
2012 CAD software. The 5-layer disc (Fig. 1C) comprises of three 1.5-mm thick PMMA (poly methyl methacrylate) layers (Radionics, 
Ireland) and two layers of ~90 μm thin pressure sensitive adhesives (PSA, Adhesives Research, Ireland). Chambers and access holes were 
machined using a CO2 laser cutter (Zing 16, Epilog USA). The channels in the PSA were patterned using a Craft ROBO knife cutter 
(Graphtec Corp, USA). The sacrificial valves were fabricated from water dissolvable films (Adhesives Research, Ireland).(Gorkin III et al. 
2012) The individually machined disc layers were subsequently aligned and assembled using a custom-made alignment jig and a hydraulic 
laminator.(Gorkin III et al. 2012) 
2.2 Liver Assay Panel 
Albumin (ALB) is the most abundant protein in blood plasma and is made by the liver. It is responsible for transporting fat soluble 
hormones, maintains the acid-base balance and oncotic pressure.(Rhee 2011) A significant reduction in albumin levels would indicate 
abnormal function of the liver.(Rhee 2011) The assay reagent – Bromo-cresol green is a dye that binds to human ALB, producing a colour 
change which is detectable at 630 nm. Normal clinical range for ALB is 35 – 50 g/L. Similarly, bilirubin is found in blood plasma, a product 
of haemoglobin breakdown. It is the water-insoluble product left over as old red blood cells are broken down on daily basis. In the liver, it is 
made water soluble for excretion. High levels of bilirubin can indicate liver damage, and recently have also been associated with heart 
failure.(van Deursen et al. 2010) The total bilirubin (TBIL) assay measures all bilirubin in the blood, whether or not it has been metabolised 
by the liver. The direct bilirubin (DBIL) assay measures the bilirubin that has been made water-soluble by the liver. The TBIL assay initiates 
a colour change detectable at 578 nm while absorbance for the DBIL assay is at 546 nm. Normal clinical range for TBIL is 0 – 17 μmol/L 
while that of DBIL is 0 – 4 μmol/L. 
Alkaline phosphatase (ALP) and γ-glutamyltransferase (GGT) enzymes are quite similar in their determination of liver function. High levels 
of ALP can indicate biliary obstruction.(Hughes and Jefferson 2008; Vella et al. 2012) High blood plasma GGT levels are associated 
primarily with liver damage.(Burtis et al. 2008) When there is liver disease, ALP and GGT increase roughly in equal amounts.(Hughes and 
Jefferson 2008) The ALP and GGT assays depend on the enzymes acting on artificial substrates to give changes in absorbance at 405 nm. 
The normal adult range for ALP is 30 – 130 U/L, while GGT is 4 – 28 U/L.(Burtis et al. 2008) 
2.3 Liver Assay Tests on benchtop, disc platform and standard hospital laboratory 
Standard assay reagents for five enzymatic assays on albumin (ALB), alkaline phosphatase (ALP), gamma glutamyl transferase (GGT), total 
(TBIL) and direct (DBIL) bilirubin, which are similar to those used in a hospital laboratory setting for these biomarkers of liver function, 
were purchased from Randox Chemicals, United Kingdom. On the benchtop, the colorimetric LAP was run on a standard transparent 96-well 
plate according to the manufacturer’s instructions. Absorbance measurements were performed using an Infinite M200 spectrophotometric 
microplate reader (Tecan Group Ltd, Männedorf, Switzerland). Following miniaturisation and optimisation, the assay was transferred onto 
the LoaD platform. BR411 assay kit was used for total bilirubin (TBIL). For this assay, 20 μl of reagent (r1) 100 μl (r2) and 100 μl (r8) were 
loaded in chambers c1, c2 and c8 respectively (Fig. 2IA). AB362 assay kit was used for albumin (ALB) assay and 100 μl of (r3) was loaded 
in chamber c3. The γ-glutamyltransferase (GGT) assay was run using GT 2750 assay kit which required loading 100 μl (r4) in chamber c4. 
For alkaline phosphatase (ALP), the AP311 assay kit which necessitates the addition of 50 μl (r9) and 100 μl (r5) in chambers c9 and c5 
respectively. The direct bilirubin (DBIL) assay used the BR2362 assay kit; 20 μl (r6) and 100 μl (r7) were loaded in chambers c6 and c7 
respectively (Fig. 2IA). The calibrator CAL2350, which was reconstituted with 4 ml of ultrapure water, and diluted in series, was used to 
standardize the assay panel, according to manufacturer’s specifications. The full calibration range was performed in triplicate, on separate 
LoaD platforms. In this study, micropipettes were used to introduce the assay reagents and samples onto the LoaD platform prior to running 
the tests (Fig 1A). 150 μl of whole blood was obtained from a finger-prick and micro-pipetted into the blood separation chamber, having pre-
loaded the assay reagents in their respective chambers (Fig. 1B and 2I). However, in order to account for pipetting, CMAS and disc 
manufacturing errors; one-point calibration using the calibrator CAL 2350 was run twice daily, on the calibration section of the disc (Fig 
1B). This is particularly beneficial for field trips. The entire optimized spinning protocol and absorbance measurements were carried out on 
the CMAS. On the other hand, for benchtop experiments, sample preparation was carried out by centrifuging whole blood sample in a tube at 
10,000 rotations per minute (rpm) for 5 min, after which the blood plasma was taken out and used for the experiments. 
Blood samples were obtained from healthy donors. Approval for use of blood was obtained from the university ethics committee and the 
donors signed informed consent. The same blood sample was sent through the student health centre to the hospital lab of Mater 
Misericordiae University Hospital, Dublin for reference tests on the same day. For the preliminary field trial runs, the CMAS was transported 
to a PEPFAR centralised government laboratory at Abia State University Teaching Hospital (ABSUTH), Nigeria. Calibration and assays 
were carried out using reagents regularly used at the hospital lab on the LoaD platforms. For this preliminary field trial, three biomarkers 
(ALB, ALP and Total protein) of liver function were tested. 
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2.4 Portable centrifugal microfluidic analytical system (CMAS) 
CMAS incorporates wireless communication and is powered via two 9-V lithium polymer batteries. A Pololu Wixel-based general-purpose 
programmable module was based on a TI CC2511F32 microprocessor. System control and data acquisition are wirelessly enabled in real 
time by Bluetooth communication (BlueSMiRF RN-42) with a custom-designed application on an Android tablet (Samsung Galaxy Tab with 
7-inch screen, Fig. 1A). The software was programmed for real-time display of the results, internal data storage and data connectivity to the 
cloud, either via a mobile network or WiFi.  
 The spinning protocol of the disc is controlled by a pulse-width modulated (PWM) motor (Mabuchi Motor RF-500TB). The actual rotational 
frequency is calculated using an optical switch (Optek OPB830L51) and rotating interrupter. In order to protect the electronics and to 
minimize interferences from ambient light during the operation of the device, the ProEngineer designed CMAS case was fabricated using a 
3D printer (Stratasys, USA) in acetonitrile butadiene styrene co-polymer (ABS).  
Table 1 Spectral range, maximum absorbance and emitter LEDs used for the LAP 
Assay panel Wavelength [nm] Spectral range Max. absorbance Emitter LED
TBIL 560 – 600 578 569 
ALB 600 – 650 626 626 
GGT 400 – 420 400 405 
ALP 400 – 420 400 405 
DBIL 530 – 560 546 540 
 
The colorimetric detection systems are based on a low cost paired emitter detector diode (PEDD). The PEDD device consists of two 5-mm 
light emitting diodes, one serving as the light source and the other, in reverse bias mode, as the detector.(de Vargas-Sansalvador et al. 2011a; 
M. O’ Toole et al. 2007) A detailed description of the CMAS including the PEDD detection technique can be found in Czugala et 
al.(Czugala et al. 2013) To maximise sensitivity, the emission spectrum of the emitter LEDs is chosen to overlap with the UV-vis absorbance 
maximum (λmax) of each assay. Therefore, LEDs with λmax at 626 nm (ALB), 405 nm (ALP, GGT), 540 nm (DBIL) and 569 nm (TBIL) 
were employed (Table 1). A common, 660-nm LEDs served as detector as the LED is sufficiently sensitive through the spectrum below the 
emission wavelength.(Lau et al. 2004) 
 
3. Results and Discussion 
3.1 System integration and automation 
Centrifugo-pneumatic DF valves (Gorkin III et al. 2012) sealed by vertical through holes in a 3D, multi-layer microfluidic channel 
architecture on the disc (Figs 1C & 2A).  
Table 2 Full spinning protocol for the LAP. 
Step Rotational Frequency [RPM] Operation 
Duration 
[min] 
1 2000 Blood plasma separation and delivery of first set of assay reagents 5 
2 150 Siphon priming by capillary action 2 
3 1000 Aliquoting of sample into six separate aliquoting chambers 3 
4 2500 Actuation of the DF valves and sample delivery 3 
5 2500; 1000 Mixing and incubation by spinning at high and low frequencies 2 
6 4000 Delivery of second set of assay reagents 3 
7 0 PEDD detection 1a 
a Except for the GGT kinetic assay, whose read out takes 4 minutes. 
 
A detailed spinning protocol employed for the entire LAP after pre-loading all reagents and sample is given in Table 2. The entire assay 
sequence which involves blood separation, reagent delivery, plasma extraction, aliquoting and metering, sample delivery, mixing, incubation 
and detection is completed in ~20 min. A colour-coded schematic of the fluidic control and routing for the entire LAP sequence on-disc is 
given in Fig. 2I. Figure 2II demonstrates with frame sequence images the advanced fluidic control for the LAP, indicating the rotational 
frequencies and time for each operation. The red dotted arrows in Fig. 2II indicate the fluidic movement for that operation. 
In order to enhance contrast in Fig. 2II, whole blood and food dye were used to demonstrate the liquid handling sequence. A video of the full 
LAP with assay reagents can be found in the ESI. As shown in Fig. 2I, the aliquoting chambers were designed to meter 15 μl of sample for 
TBIL and DBIL assays and 10 μl for ALB, GGT and ALP assays, respectively.  
This disc was designed such that the radial positioning of the DF valves to be actuated simultaneously is the same. 
The centrifugal pressure at the DF valves (Madou et al. 2006) depends on the mean radial position r
G
, length Δr and 
density ρ of the liquid plug and the angular velocity ω of the disc. 
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3.3 Liver function tests 
Once the calibration method was established, we analysed the liver panel biomarkers in blood samples. As shown in Fig. 3F and Table S3 
(see ESI), the results obtained using the CMAS platform are well within the error bars of the well-plate reader and hospital laboratory tests. 
An unpaired two sample t-test with unequal variance was used to compare the mean of the measurements obtained using the CMAS and 
benchtop well-plate reader with a null hypothesis of equal means. The two-tailed t-test with 8 degrees of freedom gave a p value of 0.94 and 
t-statistic of 0.078. While failing to reject the null hypothesis, the results suggest that there is no statistical difference between the mean of 
the measurements (with 94% certainty of equivalence) obtained using the CMAS and the benchtop well-plate reader. A similar statistical 
comparison between CMAS and hospital laboratory results with 14 degrees of freedom gave a p value of 0.92 and t-statistic of 0.106, 
suggesting no statistical difference between the means of both measurements (with 92% certainty of equivalence).   
Results of the in-situ preliminary trials from a government-funded centralised laboratory at ABSUTH, Nigeria are given in Table 3. Using 
reagents at the lab, three liver assays (ALB, ALP and Total protein) were run on our portable LoaD system. The results shown in Table 3 are 
only preliminary and indicative; yet, they demonstrate that our system has the potential to be deployed for on-field screening tests and in 
community health centres.  
 
Table 3 Comparison of preliminary test results obtained from the CMAS and a centralised hospital in Nigeria. 
 CMAS 
(Nigeria) 
Centralised lab 
(Nigeria) 
Reference 
range 
ALB [g/L] 46 ± 5.2 37 37 - 54 
ALP [U/L] 42 ± 6.4 35 25 - 92 
Total protein [g/L] 69 ± 3.7 57 60 - 77 
4. Conclusions and Outlook 
 We have developed a fully integrated and automated centrifugal microfluidic platform and a low-cost LED-based centrifugal microfluidic 
analytical system. A liver assay panel comprising of five independent enzymatic assays that determine liver function was integrated on this 
system. Our uniquely designed microfluidic disc enabled the running of the complete assay panel from single loading of whole blood sample 
obtained from a finger prick of blood.  
In comparison to the Tecan plate reader, the CMAS platform provides comparable results within a handheld mobile device, which in turn 
allows for a true point-of-care diagnostic. Furthermore, our system was deployed to a remote centralized laboratory in Nigeria, a Sub-
Saharan African country for preliminary field trials. The results indicate that this device can potentially be used for on-field screening tests, 
thus helping patients to get efficient and appropriate treatments. 
The level of full integration and automation on the CMAS platform makes it amenable for on-field screening tests by quickly trained 
personnel. Furthermore our system has minimal reagent requirements (e.g. 100 µl versus 1 ml of assay reagent for the TBIL assay, thus 
notably reducing the cost per test on the CMAS platform. Portability, which is the hallmark of our system when compared to benchtop and 
other systems (e.g. Abaxis 2012; Lee et al. 2009) lends it for in-situ routine monitoring and on-field screening. Such high, on-site availability 
is vital for early detection, permitting timely change of medication and efficient treatment of fatal (liver) disease. Other significant 
advantages include increased sample throughput due to minimal human intervention and shorter incubation times. Results can also be 
transferred to remote locations, displayed in real time and stored on web-databases for location independent access. As a result of all these 
features, our system allows for de-centralised testing which is particularly important in low-resource economies where significant 
transportation and logistics challenges exist. 
We will further optimise the LoaD platform, carry out further validation tests, expand the scope of assay panel and make this rugged, 
portable, multi-purpose and cost-efficient point-of-care diagnostic available to resource-poor economies. 
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Table S1 Results obtained using the CMAS platform, Well-plate reader and hospital laboratory tests for liver function monitoring tests. 
Liver assays Hospital clinic datawell–plate reader CMAS Normal clinical range
(n = 3) (n = 3) 
ALB [g/l] 41 44.3 ± 2.0 45.77 ± 1.23 35 – 50 
TBIL [µmol/l] 19 17.0 ± 2.1 22.07  ± 2.53 5 – 24 
ALP [I.U./l] 83 84.9 ± 2.7 81.15 ± 2.02 30 – 130 
GGT [I.U./l] 18 16.9 ± 3.1 20.78 ± 3.67 11 – 67 
 
 
 
 
 
 
Table S2 Raw data obtained using the CMAS platform to run the calibration standard tests. 
ALB assay 
 
Concentration [g/l] 
Average discharge time 
[µs] (n = 3) 
 
StDev  
(n = 3) 
 
0 2585 0.03 
1.4 3474 5 
2.1 4019 1 
3.2 4662 2 
4.8 6117 11 
7.2 8877 9 
10.8 13892 71 
16.3 20778 13 
24.4 33882 86 
54.9 64600 124 
 
ALP assay 
 
Concentration [I.U. 
/l] 
Average discharge 
time [µs] (n = 3) 
 
StDev  
(n = 3) 
 
0.8 31521 110 
6.2 31718 205 
14.0 32121 265 
47.1 34521 140 
106.0 39680 288 
159.0 44619 1108 
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TBIL assay 
Concentration [µmol/l] 
Average discharge 
time [µs] (n = 3) 
StDev  
(n = 3) 
0 27641 1617 
2.1 27663 195 
4.8 28158 115 
16.3 28602 372 
54.9 30254 181 
 
GGT assay 
Concentration 
[I.U./l] 
Average 
discharge time 
[µs]  
(n = 3) 
 
StDev  
(n = 3) 
 
0 36403 244 
1.9 36574 225 
4.2 37032 207 
9.5 38244 146 
21.3 39837 511 
48 42933 444 
 
 
Highlights 
 
• We present a portable, battery-powered, fully integrated and automated microfluidic analyser 
• The compact centrifugal system parallelized a multi-parameter liver assay panel from whole blood 
• The  portable device was deployed for liver function screening tests at a HIV clinic in West Africa  
• Results demonstrate the system has the ruggedness for in-situ liver function screening 
 
